SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice

Cardiovascular disease (CVD), including heart failure (HF), is a leading cause of morbidity and mortality in people with type 2 diabetes mellitus (T2DM). CVD and T2DM share common risk factors for development and progression, and there is significant overlap between the conditions in terms of worsen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Amar, Bain, Steve, Hicks, Debbie, Newland Jones, Phillip, Patel, Dipesh C., Evans, Marc, Fernando, Kevin, James, June, Milne, Nicola, Viljoen, Adie, Wilding, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778582/
https://www.ncbi.nlm.nih.gov/pubmed/31290126
http://dx.doi.org/10.1007/s13300-019-0657-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778582/
https://www.ncbi.nlm.nih.gov/pubmed/31290126
http://dx.doi.org/10.1007/s13300-019-0657-8

Ejemplares similares